These two disorders share many features, making proper diagnosis a challenge. Treatment providers must be aware that some ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

S, Clinical Rater with BioBehavioral Research of Austin (BBRA) stopped by Studio 512 to talk about what BBRA does, and her ...

A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.

Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar ...

Although medication is the primary treatment for bipolar disorder, adding specific vitamins or supplements ... as an essential drug and is also FDA approved, per research. It is often used for ...

Rozanolixizumab-noli (Rystiggo) was approved for the treatment of MG in 2023. You’ll receive it under your skin (subcutaneously). In 2021, the Food and Drug Administration (FDA) approved an ...

The FDA has approved these drugs to treat ADHD ... while 1 in 13 has coexisting bipolar disorder. Below are a few examples of other treatment options that may help with adult ADHD: Learn more ...